Brief Report: Clinical and Molecular Phenotypes of Low‐Penetrance Variants of <i><scp>NLRP</scp>3</i>: Diagnostic and Therapeutic Challenges

Abstract

Patients with low-penetrance NLRP3 variants display a distinct clinical phenotype and an intermediate biologic phenotype, including IL-1β and non-IL-1β-mediated inflammatory pathway activation.